There's Hope for People with Age-Related Macular Degeneration
San
Francisco CA, 5 February 2004
Source: American Academy of Ophthalmology
February
is Age-Related Macular Degeneration and Low-Vision Awareness Month
Although
Age-Related Macular Degeneration (AMD) is the leading cause of visual
impairment in Caucasians over the age of 50 in the United States,
affecting more than 1.5 million people, there is hope. As part of
AMD/Low-Vision Awareness Month in February, the American Academy
of Ophthalmology, the Eye MD Association, reminds people there are
options.
Although
there is no known cure for AMD, recent research and new treatments
are showing great promise. The treatments proven to help include:
-
Photodynamic
therapy: This is a treatment that combines laser surgery
with use of light-sensitive drugs, and has been shown to stabilize
or improve vision in up to 60 percent of patients with the wet
form of AMD. The Food and Drug Administration has approved this
therapy.
-
Vitamin
and mineral supplementation: The Age-Related Eye Disease
Study found that high levels of antioxidants and zinc can reduce
the risk of vision loss by about 25 percent in high-risk patientsthose
with intermediate AMD in one or both eyes and those with advanced
AMD in only one eye. Smokers and ex-smokers should not use beta
carotene because studies have shown an association with lung
cancer and beta carotene in smokers.
For
people who have lost vision from AMD, rehabilitation to maximize
function and independence is important. Academy spokesperson Lylas
G. Mogk, MD, Director of the Visual Rehabilitation and Research
Center of the Henry Ford Health System, and chair of the Academy's
Vision Rehabilitation Committee, said, "Vision loss causes more
depression than any other physical impairment. This depression doesn't
depend on how much vision is lost, but rather on how much function
is lost performing one's daily activities. The tools, training and
resources are available to help those with macular degeneration
live full and independent lives despite vision loss."
AMD
is a progressive disease that affects the macula, the spot on the
retina at the back of the eye responsible for central vision, causing
central vision to blur, but leaving peripheral vision intact. The
two types of AMD are dry, or atrophic, and wet, or exudative. Approximately
90 percent of people with AMD have the dry form, which is caused
by aging and thinning of the macula. Although only 10 percent of
people with AMD have the wet form, it is this form that causes 90
percent of visual impairment. Wet AMD is characterized by the growth
of abnormal retinal blood vessels that leak blood or fluid, causing
rapid and severe central vision loss.
Risk
factors for AMD include:
- Smoking
- High
blood pressure
- Use
of thyroid hormones and antacids
- Use
of diuretics or presence of arthritis
- Farsightedness
- High
body mass index, a measure of obesity
The
Academy encourages those over 50 to see an Eye MD for a comprehensive,
dilated eye examination every one to two years to help ensure that
AMD and other vision-threatening conditions are detected and treated
early.
The
American Academy of Ophthalmology is the world's largest association
of eye physicians and surgeonsEye MDswith more than
27,000 members worldwide. For more information about eye health
care, visit the Academy's partner website, the Medem Network, at
www.medem.com/eyemd.
To find an Eye MD in your area, visit the Academy's website (shown
below).
Source
American
Academy of Ophthalmology (www.aao.org).
|